Heterotopic Pregnancy
Journal Title: Gynecology and Obstetrics Research – Open Journal - Year 2015, Vol 2, Issue 4
Abstract
Heterotopic pregnancy is a rare gynaecological condition whereby there is a presence of an intrauterine pregnancy and extrauterine pregnancy at the same time. It was first defined by Duverney in 1708 as an autopsy finding in a patient who had died of a ruptured ectopic pregnancy and had an intrauterine pregnancy.1 Rarely an intrauterine twin gestation can co-exist with a heterotopic pregnancy or vice versa. Higher order heterotopic gestations are extremely rare.2 This condition may cause diagnostic difficulties and the patient may collapse and die during investigations. Those occurring after fertility treatments may face ethical and emotional dilemma of having to lose one of their babies. It is a rare life-threatening condition that very few clinicians would come across during their careers. It is therefore an important clinical condition, hence the need to bring the subject prominence through a review article like this one.
Authors and Affiliations
Solwayo Ngwenya
Female Genital Schistosomiasis: A Neglected Tropical Disease
Female genital schistosomiasis is a neglected tropical disease. Few clinicians consider it in their differential diagnosis. Yet this disease affects hundreds of millions of people. Hundreds of thousands of them actually...
Bisphenol Compounds on Human Reproduction Health
Bisphenol-A (BPA) is widely used in the plastic industry, and it is one of the well-studied endocrine disrupting chemicals (EDCs). Growing evidence raised the concern of BPA having weak estrogenic activity on human healt...
Heterotopic Pregnancy: A Case Report of Retrospective Diagnosis Following Surgical Treatment
Introduction: Heterotopic pregnancy is a rare occurrence. Very few clinicians may come across heterotopic gestations during their careers. It is a difficult condition to diagnose. It can lead to maternal mortality. Case...
Pregnancy in Takayasu Arteritis Patients Exposed to Anti-Tumour Necrosis Factor (Anti-TNF)-α Therapy
Anti-TNF agents, IFX in particular,1 appear safe and effective in rheumatic patients during pregnancy. Here, we described two successful pregnancies of TA patients treated with IFX before conception and until 28 wg. Bloo...
Human Placentas and the Changing Face of Reproductive Toxicology Testing
Pharmaceuticals are in use by 40-98% of pregnant mothers in the developed world, varying by country. There is a significant potential for obstetricians to further maintain medical prescriptions for chronic diseases durin...